share_log

Bluebird Bio shares are trading higher after Barclays upgraded the stock from Underweight to Equal-Weight and raised its price target from $3 to $5.

Bluebird Bio shares are trading higher after Barclays upgraded the stock from Underweight to Equal-Weight and raised its price target from $3 to $5.

在巴克萊將藍鳥生物的股票評級從減持上調至持平，並將目標價從3美元上調至5美元后，藍鳥生物的股價上漲。
Benzinga ·  2022/08/06 02:25

Bluebird Bio shares are trading higher after Barclays upgraded the stock from Underweight to Equal-Weight and raised its price target from $3 to $5.

在巴克萊將藍鳥生物的股票評級從減持上調至持平，並將目標價從3美元上調至5美元后，藍鳥生物的股價上漲。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論